Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 183 entries
View as:

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient with Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

Phase: N/A Priority: Normal
NCT ID: NCT06789081 Org: User:
Start: 04/30/25 End: 04/30/26 Due: 04/30/27

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

Phase: N/A Priority: Normal
NCT ID: NCT01014065 Org: User:
Start: 07/31/11 End: 01/31/13 Due: 01/31/14

Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00375700 Org: User:
Start: 11/30/06 End: 01/31/10 Due: 01/31/11

A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01586611 Org: User:
Start: 06/30/12 End: 06/30/15 Due: 06/30/16

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Phase: N/A Priority: Normal
NCT ID: NCT00756691 Org: User:
Start: - End: - Due: -

High Heated Humidity in Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05358262 Org: User:
Start: 11/05/24 End: 01/31/26 Due: 01/31/27

A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04149444 Org: User:
Start: 02/29/20 End: 06/09/20 Due: 06/09/21

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00131599 Org: User:
Start: 08/31/02 End: 07/31/17 Due: 07/31/18

Multi-Parametric Brain Cancer MRI

Phase: N/A Priority: Normal
NCT ID: NCT02649699 Org: User:
Start: 04/14/16 End: 06/25/21 Due: 06/25/22

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Phase: N/A Priority: Normal
NCT ID: NCT00813787 Org: User:
Start: 02/28/09 End: 04/30/15 Due: 04/30/16

Tomosynthesis in Screening Mammography

Phase: N/A Priority: Normal
NCT ID: NCT01086241 Org: User:
Start: 05/31/10 End: 04/30/14 Due: 04/30/15

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Phase: N/A Priority: Normal
NCT ID: NCT00168116 Org: User:
Start: 07/31/00 End: 06/30/09 Due: 06/30/10

iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04808791 Org: User:
Start: 10/27/21 End: 07/21/23 Due: 07/21/24

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00813540 Org: User:
Start: 03/31/09 End: 05/31/12 Due: 05/31/13

Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation

Phase: N/A Priority: Normal
NCT ID: NCT04328246 Org: User:
Start: 02/26/21 End: 03/14/22 Due: 03/14/23

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00322985 Org: User:
Start: 06/30/06 End: 07/31/14 Due: 07/31/15

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00765986 Org: User:
Start: 10/31/08 End: 10/31/15 Due: 10/31/16

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01740271 Org: User:
Start: 12/31/12 End: 06/30/25 Due: 06/30/26

Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology

Phase: N/A Priority: Normal
NCT ID: NCT00330109 Org: User:
Start: 06/30/06 End: 12/31/17 Due: 12/31/18

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00754078 Org: User:
Start: 09/30/08 End: 10/31/16 Due: 10/31/17

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Phase: N/A Priority: Normal
NCT ID: NCT00137488 Org: User:
Start: 11/30/05 End: - Due: -

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Phase: N/A Priority: Normal
NCT ID: NCT00137475 Org: User:
Start: 02/28/02 End: 08/31/12 Due: 08/31/13

Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00522262 Org: User:
Start: 06/30/02 End: 07/31/07 Due: 07/31/08

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Phase: N/A Priority: Normal
NCT ID: NCT02080078 Org: User:
Start: 09/30/14 End: 04/30/19 Due: 04/30/20

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01034787 Org: User:
Start: 08/17/09 End: 08/08/17 Due: 08/08/18